Events

Rappel de Stent for blood vessels

Selon Korean Food & Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à South Korea qui a été fabriqué par Boston Scientific Korea Co.,.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    736
  • Date
    2017-11-10
  • Pays de l'événement
    South Korea
  • Source de l'événement
    KFDA
  • URL de la source de l'événement
    https://emed.mfds.go.kr
  • Notes / Alertes
    Korean data is current through September 2018. All of the data comes from Korean Food & Drug Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and South Korea.
  • Notes supplémentaires dans les données
    13-699

Device

Stent for blood vessels

Manufacturer

Boston Scientific Korea Co.,
  • Adresse du fabricant
    Seoul, Korea
  • Société-mère du fabricant (2017)
    Boston Scientific
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    KFDA